Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from SCRIP

13:21 EST 18th February 2018 | BioPortfolio

Here are the most relevant search results for "SCRIP" found in our extensive news archives from over 250 global news sources.

More Information about SCRIP on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SCRIP for you to read. Along with our medical data and news we also list SCRIP Clinical Trials, which are updated daily. BioPortfolio also has a large database of SCRIP Companies for you to search.

Showing News Articles 1–25 of 3,100+ from SCRIP

Friday 16th February 2018

AstraZeneca's Imfinzi Scores First Early Lung Cancer Approval

Unlike other indications PD-1/L1 inhibitors are shooting for, Stage III non-small cell lung cancer is an untapped market and AstraZeneca...   

Heart Failure Pipeline Review: Amgen's Omecamtiv And Merck's Vericiguat Step Up To Plate

In addition to small molecules, stem cell therapies promise to help rejuvenate the chronic heart failure pipeline, but high prices...   

More GRASE Time For 6 OTC Antiseptic Ingredients But 24 Flushed In Final Rule

An FDA final rule rejects generally regarded as safe and effective status for 24 OTC monograph antiseptic ingredients regarding products...   

HHS Chief Scores With Congress On DME Bid Program, Telehealth Pay, But Says LDTs Complex

At back-to-back congressional hearings on Feb. 14 and 15, US Health and Human Services Secretary Alex Azar seemed to satisfy...    

Asia Reg Roundup: Philippines Sets Short Reg System Deadline, Vietnam Defers, Malaysia Extends

New regulatory systems for devices are proliferating in the ASEAN and South-East Asia region. Some have set short compliance deadlines...   

FDA Broadens Nicotine Therapy Indication Review With Steering Committee Docket

FDA seeks broader guidance than comments and information submitted at a January public hearing on standards testing and evaluations that...  

Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...   

Celgene's IBD Franchise Boosted by Otezla Ulcerative Colitis Success

The big-selling psoriasis drug has achieved healthy clinical remission rates in a Phase II trial for ulcerative colitis, and Celgene...   

Pay, Patriots And The Art of Promise: What Results Season Taught Us

Most of the biggest pharmaceutical companies that pay taxes in Europe or North America have told the world how they...    

Santhera Expands Pipeline With Polyphor Cystic Fibrosis Deal

Santhera has moved into cystic fibrosis via a global licensing deal with Polyphor, expanding its rare disease pipeline.   

Thursday 15th February 2018

Eggs May Be Culprit In Poor Flu Vaccine Performance This Year

US health authorities, manufacturers investigating why egg-based product appears to have lower effect in adults compared to cell-based flu vaccine.   

Fight Brewing In Congress Over Part D Coverage Gap Discounts

Disease-Specific Guidances Reflect US FDA's 'Nimble, Collaborative, Patient-Focused' Approach

Patient groups helped with draft guidance on ALS drug development and revision of Alzheimer's draft guidance; agency also issues draft...  

Alzheimer's Biomarkers Gain Prominence In Drug Development Guidance

US FDA revises draft guidance issued in 2013 to allow research targeting cognition as single endpoint and studies solely evaluating...   

Sun Q3 Profits Dive, Halol Resolution Stays Pivotal To Trigger Reset

Sun Pharma reported a sharp decline in Q3 profits, dented by tax adjustments related to changes in US tax rates...    

An Image To Maintain: GAO Profit Picture Of Drug Industry Is Good To Store Away For Future Debates

Big pharma has been highly successful at changing the debate from the level of drug company profitability to who shares...   

Pacira's Exparel: US FDA Panel Narrowly Rejects Nerve Block Claim

Inconsistent efficacy data and safety concerns about falls and systemic toxicity lead to advisory committee vote against a labeling expansion...    

Warning On TCM Claim, CRN Counsel, UNPA Asia: Health And Wellness News

'Chinese medicine' claim trips Reishi D.; Olsen joins CRN as assistant general counsel; and UNPA Asia Report in 'Asiaceutical Insights'.   

House Bill Seeks Asbestos Warnings On Unverified Kids' Cosmetics With Talc

The Children’s Product Warning Label Act of 2018 would give parents "peace of mind in knowing that the cosmetics they...   

Pfizer/Merck KGAA's Bavencio Fails OS Endpoint In Second-Line Lung Cancer

The firms still hope to produce positive data in first-line non-small cell lung cancer in 2019, but Bavencio is falling...   

FDA Deputy On CRLs: 'It's Not Our Property To Release'

US FDA Principal Deputy Commissioner Rachel Sherman said during the BIO CEO & Investor conference that while investors and...   

BiomX Wants To Reverse The Focus Of Microbiome Therapy

Emerging Company Profile: Where other microbiome-focused firms seek to add bacteria to the patient's gut, Israel's BiomX thinks it can...   

First Concussion Blood Test Leverages De Novo, Breakthrough Pathways

The Banyan Brain Trauma Indicator is the first blood test for detecting concussions in adults to reach the US market...    

Ipsen CEO To Feed Group's Three Therapeutic Engines Fresh Assets In 2018

CEO David Meek Says Ipsen has more than $1bn for M&A use to expand its product line in oncology, neuroscience...    

Interview: Ferring Forges Ahead With mAbs For Reproductive Meds

Antibody-based therapies have not really been investigated in the area of reproductive medicine and women’s health but Ferring is investing...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks